Mgo One Seven LLC Ultragenyx Pharmaceutical Inc. Transaction History

Mgo One Seven LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$45.8 - $85.4 $21,022 - $39,198	-459 Reduced 9.28%	4,488 $268,000
Q1 2022 May 13, 2022	BUY	$62.2 - $84.4 $62 - $84	1 Added 0.02%	4,947 $359,000
Q4 2021 Feb 09, 2022	SELL	$73.71 - $87.86 $50,343 - $60,008	-683 Reduced 12.13%	4,946 $416,000
Q3 2021 Nov 09, 2021	BUY	$77.92 - $102.4 $77 - $102	1 Added 0.02%	5,629 $472,000
Q2 2021 Jul 29, 2021	SELL	$92.19 - $115.71 $64,533 - $80,997	-700 Reduced 11.06%	5,628 $537,000
Q1 2021 Apr 29, 2021	SELL	$106.9 - $167.73 $2,779 - $4,360	-26 Reduced 0.41%	6,328 $720,000
Q4 2020 Jan 22, 2021	SELL	$84.4 - $177.39 $27,008 - $56,764	-320 Reduced 4.79%	6,354 $880,000
Q3 2020 Oct 30, 2020	BUY	$72.98 - $90.0 $487,068 - $600,660	6,674 New	6,674 $549,000
Q3 2018 Oct 09, 2018	SELL	$71.81 - $90.15 $430 - $540	-6 Closed	0 $0
Q4 2017 Feb 16, 2018	BUY	$43.54 - $57.32 $261 - $343	6	6 $0

325

85.5M

520K

406K

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.14B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

Get notified when there are updates to the investment portfolio of Mgo One Seven LLC, based on Form 13F filings with the SEC.

Stay updated on Mgo One Seven LLC with notifications on news.